Review By on April 6, 2018

Mahickra Chemicals Ltd. (MCL) is in the business of manufacturing of Reactive Dyes since year 1998, while the business of trading in Reactive Dyes was started in year 1994. The Company manufactures Reactive Dyes also known as Synthetic Organic Dyes (S.O. Dyes) and has an integrated process. The company specializes in Black Reactive Dyes. It manufactures 40 various types of Reactive Dyes. The product of the company caters to textiles & garments manufacturers. The company also offers specialty performance chemicals to the Textile Dyeing and printing industry. The company has a production capacity of approx. 900 tons per annum. The manufacturing facility of the company is situated at Vatva GIDC in Gujarat. MCL is an ISO 9001:2015, ISO 14001:2015 and GOTS certified company certifying the quality of the product it manufactures.
To part finance its working capital and general corpus fund needs, MCL is coming out with a maiden IPO of 2100000 equity shares of Rs. 10 each via book building route with a price band of Rs.24 – Rs. 25 to mobilize Rs. 5.04 to Rs. 5.25 crore (based on lower and upper price bands). Issue opens for subscription on 16.04.18 and will close on 18.04.18. Minimum application is to be made for 6000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. Issue is solely lead managed by Pantomath Capital Advisors Pvt. Ltd. and Bigshare Services Pvt. Ltd. is the registrar to the issue. Issue constitutes 29.05% of the post issue paid up capital of the company. Having raised initial equity at par it raised further equity in the price range of Rs. 20 and Rs. 24 in December 2017 and January 2018 respectively. Average cost of acquisition of shares by the promoters is Rs. 10 and Rs. 11.33 per share. Post issue, MCL's current paid up capital of Rs. 5.13 crore will stand enhanced to Rs. 7.23 crore.
On performance front, MCL has posted turnover/net profits of Rs. 43.56 cr. / Rs. 0.17 cr. (FY14), Rs. 42.75 cr. / Rs. 0.09 cr. (FY15), Rs. 34.79 cr. / Rs. 0.15 cr. (FY16) and Rs. 42.26 cr. / Rs. 0.35 cr. (FY17). For the current fiscal it has shown two breaking periods of performance from 01.04.17 to 12.11.17 and from 13.11.17 to 31.12.17. It we combined both then it has earned net profit of Rs. 0.36 cr. on a turnover of Rs. 40.90 crore for first nine months. It suffered a setback in top line for FY 16 and sudden jump in bottom line for FY 17 raising concern. Except FY16, its top line remained mostly static between FY14 and FY17. For last three fiscals it has posted an average EPS of Rs. 0.73 and an average RoNW of 11.62%. Issue is priced at a P/BV of 1.88 based on its NAV of Rs. 13.27 as on 31.12.17. If we annualize latest earnings and attribute it on fully diluted equity post issue, then asking price is at a P/E of around 37 plus against industry average of 27. Thus issue is priced very aggressively. Its listed peers are trading at a P/E of around Aksharchem (14), Kiri Ind. (12), Camex (34) and Meghmani Orga (31) – (as on 05.04.18 closing on BSE). Company is having higher inventory carry over and is mounting year on year that raises concern.
On merchant banker's front, this is the 68th mandate since fiscal 2015-16. Out of last 10 listings (including that of Benara Bearings) 1 opened at a discount and the 8 at a premium ranging from 1.6% to 20% on SME platform and 1 at a premium of 130% on main board on the day of listing.

Review By on April 6, 2018
Dilip Davda is a veteran financial journalist associated with the Indian stock market since 1978. He has been contributing to print and electronic media on capital markets, insurance, and finance since 1985.
He is widely recognized for reviewing public issues and non-convertible debentures (NCDs) in the primary market. Drawing on over three decades of market experience and close interaction with merchant bankers, his reviews focus on detailed fundamental and financial analysis of companies, with a special emphasis on SME public issues.
Dilip Davda
SEBI Registered Research Analyst – Mumbai
Registration No.: INH000003127 (Perpetual)
Email: dilip_davda@rediffmail.com
Disclaimer: The information provided herein is solely for educational and informational purposes and does not constitute an offer, solicitation, or recommendation to buy or sell any securities. Readers are advised to consult a qualified financial advisor before making any investment decisions. Investments in the securities market are subject to market risks. The author does not intend to invest in the securities discussed.
The initial public offer (IPO) of Mahickra Chemicals Ltd. offers an early investment opportunity in Mahickra Chemicals Ltd.. A stock market investor can buy Mahickra Chemicals IPO shares by applying in IPO before Mahickra Chemicals Ltd. shares get listed at the stock exchanges. An investor could invest in Mahickra Chemicals IPO for short term listing gain or a long term.
Read the Mahickra Chemicals IPO recommendations by the leading analyst and leading stock brokers.
Mahickra Chemicals IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Mahickra Chemicals IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts mentioned in the above answer to "How is Mahickra Chemicals IPO?"
Our recommendation for Mahickra Chemicals IPO is to avoid.
As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the Mahickra Chemicals IPO.
The Mahickra Chemicals IPO allotment status will be available on or around April 23, 2018. The allotted shares will be credited in demat account by April 25, 2018. Visit Mahickra Chemicals IPO allotment status to check.